Charles Darwin University

CDU eSpace
Institutional Repository

CDU Staff and Student only

Plasmodium vivax trophozoites insensitive to chloroquine

Sharrock, Wesley W., Suwanarusk, Rossarin, Lek-Uthai, Usa, Edstein, Michael D., Kosaisavee, Varakorn, Travers, Thomas, Jaidee, Anchalee, Sriprawat, Kanlaya, Price, Ric N., Nosten, Francois and Russell, Bruce (2008). Plasmodium vivax trophozoites insensitive to chloroquine. Malaria Journal,7:94-100.

Document type: Journal Article
Attached Files (Some files may be inaccessible until you login with your CDU eSpace credentials)
Name Description MIMEType Size Downloads
Download this reading Sharrock_7269.pdf Published version application/pdf 1.31MB 119
Reading the attached file works best in Firefox, Chrome and IE 9 or later.

IRMA ID 10202xPUB28
Title Plasmodium vivax trophozoites insensitive to chloroquine
Author Sharrock, Wesley W.
Suwanarusk, Rossarin
Lek-Uthai, Usa
Edstein, Michael D.
Kosaisavee, Varakorn
Travers, Thomas
Jaidee, Anchalee
Sriprawat, Kanlaya
Price, Ric N.
Nosten, Francois
Russell, Bruce
Journal Name Malaria Journal
Publication Date 2008
Volume Number 7
ISSN 1475-2875   (check CDU catalogue open catalogue search in new window)
Start Page 94
End Page 100
Total Pages 7
Place of Publication London, U.K.
Publisher BioMed Central Ltd
Field of Research 1108 - Medical Microbiology
HERDC Category C1 - Journal Article (DEST)
Abstract Background
Plasmodium vivax is a major cause of malaria and is still primarily treated with chloroquine. Chloroquine inhibits the polymerization of haem to inert haemozoin. Free haem monomers are thought to catalyze oxidative damage to the Plasmodium spp. trophozoite, the stage when haemoglobin catabolism is maximal. However preliminary in vitro observations on P. vivax clinical isolates suggest that only ring stages (early trophozoites) are sensitive to chloroquine. In this study, the stage specific action of chloroquine was investigated in synchronous cryopreserved isolates of P. vivax.

The in vitro chloroquine sensitivity of paired ring and trophozoite stages from 11 cryopreserved P. vivax clinical isolates from Thailand and two Plasmodium falciparum clones (chloroquine resistant K1 and chloroquine sensitive FC27) was measured using a modified WHO microtest method and fluorometric SYBR Green I Assay. The time each stage was exposed to chloroquine treatment was controlled by washing the chloroquine off at 20 hours after the beginning of treatment.

Plasmodium vivax isolates added to the assay at ring stage had significantly lower median IC50s to chloroquine than the same isolates added at trophozoite stage (median IC50 12 nM vs 415 nM p < 0.01). Although only 36% (4/11) of the SYBR Green I assays for P. vivax were successful, both microscopy and SYBR Green I assays indicated that only P. vivax trophozoites were able to develop to schizonts at chloroquine concentrations above 100 nM.

Data from this study confirms the diminished sensitivity of P. vivax trophozoites to chloroquine, the stage thought to be the target of this drug. These results raise important questions about the pharmacodynamic action of chloroquine, and highlight a fundamental difference in the activity of chloroquine between P. vivax and P. falciparum.
DOI   (check subscription with CDU E-Gateway service for CDU Staff and Students  check subscription with CDU E-Gateway in new window)

© copyright

Every reasonable effort has been made to ensure that permission has been obtained for items included in CDU eSpace. If you believe that your rights have been infringed by this repository, please contact

Version Filter Type
Access Statistics: 180 Abstract Views, 120 File Downloads  -  Detailed Statistics
Created: Thu, 16 Apr 2009, 15:25:58 CST by Sarena Wegener